368 related articles for article (PubMed ID: 10772947)
41. Robust B cell immunity but impaired T cell proliferation in the absence of CD134 (OX40).
Pippig SD; Peña-Rossi C; Long J; Godfrey WR; Fowell DJ; Reiner SL; Birkeland ML; Locksley RM; Barclay AN; Killeen N
J Immunol; 1999 Dec; 163(12):6520-9. PubMed ID: 10586044
[TBL] [Abstract][Full Text] [Related]
42. Identification of a CD4+CD25+ T cell subset committed in vivo to suppress antigen-specific T cell responses without additional stimulation.
Nolte-'t Hoen EN; Wagenaar-Hilbers JP; Boot EP; Lin CH; Arkesteijn GJ; van Eden W; Taams LS; Wauben MH
Eur J Immunol; 2004 Nov; 34(11):3016-27. PubMed ID: 15376196
[TBL] [Abstract][Full Text] [Related]
43. The generation of T cell memory: a review describing the molecular and cellular events following OX40 (CD134) engagement.
Weinberg AD; Evans DE; Thalhofer C; Shi T; Prell RA
J Leukoc Biol; 2004 Jun; 75(6):962-72. PubMed ID: 14996827
[TBL] [Abstract][Full Text] [Related]
44. The T cell-B cell interaction via OX40-OX40L is necessary for the T cell-dependent humoral immune response.
Stüber E; Strober W
J Exp Med; 1996 Mar; 183(3):979-89. PubMed ID: 8642301
[TBL] [Abstract][Full Text] [Related]
45. Ex vivo expansion of dendritic-cell-activated antigen-specific CD4+ T cells with anti-CD3/CD28, interleukin-7, and interleukin-15: potential for adoptive T cell immunotherapy.
Chen HW; Liao CH; Ying C; Chang CJ; Lin CM
Clin Immunol; 2006 Apr; 119(1):21-31. PubMed ID: 16406844
[TBL] [Abstract][Full Text] [Related]
46. OX40-OX40 ligand interaction through T cell-T cell contact contributes to CD4 T cell longevity.
Soroosh P; Ine S; Sugamura K; Ishii N
J Immunol; 2006 May; 176(10):5975-87. PubMed ID: 16670306
[TBL] [Abstract][Full Text] [Related]
47. Prevention of diabetes in NOD mice at a late stage by targeting OX40/OX40 ligand interactions.
Pakala SV; Bansal-Pakala P; Halteman BS; Croft M
Eur J Immunol; 2004 Nov; 34(11):3039-46. PubMed ID: 15368274
[TBL] [Abstract][Full Text] [Related]
48. Ligation of OX40 (CD134) regulates graft-versus-host disease (GVHD) and graft rejection in allogeneic bone marrow transplant recipients.
Blazar BR; Sharpe AH; Chen AI; Panoskaltsis-Mortari A; Lees C; Akiba H; Yagita H; Killeen N; Taylor PA
Blood; 2003 May; 101(9):3741-8. PubMed ID: 12521997
[TBL] [Abstract][Full Text] [Related]
49. Characterization and functional study of five novel monoclonal antibodies against human OX40L highlight reverse signalling: enhancement of IgG production of B cells and promotion of maturation of DCs.
Wang Q; Chen Y; Ge Y; Sun J; Shi Q; Ju S; Dai J; Yu G; Zhang X
Tissue Antigens; 2004 Nov; 64(5):566-74. PubMed ID: 15496199
[TBL] [Abstract][Full Text] [Related]
50. Multiple levels of activation of murine CD8(+) intraepithelial lymphocytes defined by OX40 (CD134) expression: effects on cell-mediated cytotoxicity, IFN-gamma, and IL-10 regulation.
Wang HC; Klein JR
J Immunol; 2001 Dec; 167(12):6717-23. PubMed ID: 11739485
[TBL] [Abstract][Full Text] [Related]
51. OX40 ligand-transduced tumor cell vaccine synergizes with GM-CSF and requires CD40-Apc signaling to boost the host T cell antitumor response.
Gri G; Gallo E; Di Carlo E; Musiani P; Colombo MP
J Immunol; 2003 Jan; 170(1):99-106. PubMed ID: 12496388
[TBL] [Abstract][Full Text] [Related]
52. Constitutive OX40/OX40 ligand interaction induces autoimmune-like diseases.
Murata K; Nose M; Ndhlovu LC; Sato T; Sugamura K; Ishii N
J Immunol; 2002 Oct; 169(8):4628-36. PubMed ID: 12370402
[TBL] [Abstract][Full Text] [Related]
53. Amelioration of experimental autoimmune encephalomyelitis with anti-OX40 ligand monoclonal antibody: a critical role for OX40 ligand in migration, but not development, of pathogenic T cells.
Nohara C; Akiba H; Nakajima A; Inoue A; Koh CS; Ohshima H; Yagita H; Mizuno Y; Okumura K
J Immunol; 2001 Feb; 166(3):2108-15. PubMed ID: 11160262
[TBL] [Abstract][Full Text] [Related]
54. Characterization of the human CD27 ligand, a novel member of the TNF gene family.
Hintzen RQ; Lens SM; Beckmann MP; Goodwin RG; Lynch D; van Lier RA
J Immunol; 1994 Feb; 152(4):1762-73. PubMed ID: 8120385
[TBL] [Abstract][Full Text] [Related]
55. 5C6-F4, a novel 100,000-dalton rat lymphocyte activation antigen defined by monoclonal antibody.
Uede T; Kohda H; Yuasa H; Osawa H; Diamantstein T; Yodoi J; Ishii Y; Kikuchi K
J Immunol; 1986 Jun; 136(11):3968-76. PubMed ID: 3009613
[TBL] [Abstract][Full Text] [Related]
56. 4-1BB and OX40 act independently to facilitate robust CD8 and CD4 recall responses.
Dawicki W; Bertram EM; Sharpe AH; Watts TH
J Immunol; 2004 Nov; 173(10):5944-51. PubMed ID: 15528328
[TBL] [Abstract][Full Text] [Related]
57. Expression of CD30 ligand (CD153) on murine activated T cells.
Shimozato O; Takeda K; Yagita H; Okumura K
Biochem Biophys Res Commun; 1999 Mar; 256(3):519-26. PubMed ID: 10080930
[TBL] [Abstract][Full Text] [Related]
58. Expression of gp34 (OX40 ligand) and OX40 on human T cell clones.
Takasawa N; Ishii N; Higashimura N; Murata K; Tanaka Y; Nakamura M; Sasaki T; Sugamura K
Jpn J Cancer Res; 2001 Apr; 92(4):377-82. PubMed ID: 11346458
[TBL] [Abstract][Full Text] [Related]
59. Functional CD4 T cells after intercellular molecular transfer of 0X40 ligand.
Baba E; Takahashi Y; Lichtenfeld J; Tanaka R; Yoshida A; Sugamura K; Yamamoto N; Tanaka Y
J Immunol; 2001 Jul; 167(2):875-83. PubMed ID: 11441094
[TBL] [Abstract][Full Text] [Related]
60. Characteristics of inflammatory cells in spontaneous autoimmune thyroiditis of NOD.H-2h4 mice.
Yu S; Medling B; Yagita H; Braley-Mullen H
J Autoimmun; 2001 Feb; 16(1):37-46. PubMed ID: 11221995
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
